Page last updated: 2024-10-20

spermine and Graft vs Host Disease

spermine has been researched along with Graft vs Host Disease in 1 studies

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research Excerpts

ExcerptRelevanceReference
"Spermine dialdehyde (SDA), an oxidized product of spermine which irreversibly suppresses T cell and NK cell activities, was evaluated as an ex vivo purging agent in the prevention of graft-versus-host disease (GVHD) in mice transplanted with SDA-treated allogeneic bone marrow."3.68Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. ( Chourmouzis, E; Conant, JM; Lau, C; Li, D; Visconti, V; Wang, E, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, E1
Conant, JM1
Li, D1
Visconti, V1
Chourmouzis, E1
Lau, C1

Other Studies

1 other study available for spermine and Graft vs Host Disease

ArticleYear
Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model.
    Bone marrow transplantation, 1990, Volume: 6, Issue:4

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Chimera; Disease Models, Anima

1990